Axillary radiotherapy instead of axillary dissection: A randomized trial

Stefano Zurrida, Roberto Orecchia, Viviana Galimberti, Alberto Luini, Irene Giannetti, Bettina Ballardini, Andrea Amadori, Giulia Veronesi, Umberto Veronesi

Research output: Contribution to journalArticle

Abstract

Background: Surgical dissection of the axilla is a standard part of the treatment of breast cancer but, by itself, does not improve prognosis; furthermore, most patients with small-sized breast cancer and a clinically uninvolved axilla never develop axillary metastases. We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT). Methods: From 1995 to 1998, 435 patients older than 45 years with breast cancer up to 1.2 cm were randomized, 214 to breast conservation without axillary treatment and 221 to breast conservation plus axillary RT. Results: After a follow-up of 28 to 68 months (median, 42 months), two women (1%) in the no axillary treatment group and one (.5%) in the axillary RT group developed axillary metastases. Rates of distant metastases and local treatment failure were also very low, and 5-year overall survival was 99%. Conclusions: After a mean of 46 months of follow-up, our results indicate that axillary dissection can be safely avoided in patients with very small invasive carcinomas and a clinically negative axilla. Whether axillary RT should be added can be assessed only by longer follow-up.

Original languageEnglish
Pages (from-to)156-160
Number of pages5
JournalAnnals of Surgical Oncology
Volume9
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Dissection
Radiotherapy
Axilla
Breast Neoplasms
Neoplasm Metastasis
Breast
Lymph Node Excision
Treatment Failure
Disease-Free Survival
Therapeutics
Carcinoma
Survival

Keywords

  • Axillary radiotherapy
  • Breast cancer
  • Lymph nodes
  • Metastases
  • Randomized trial

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Axillary radiotherapy instead of axillary dissection : A randomized trial. / Zurrida, Stefano; Orecchia, Roberto; Galimberti, Viviana; Luini, Alberto; Giannetti, Irene; Ballardini, Bettina; Amadori, Andrea; Veronesi, Giulia; Veronesi, Umberto.

In: Annals of Surgical Oncology, Vol. 9, No. 2, 2002, p. 156-160.

Research output: Contribution to journalArticle

@article{64d699b0e27342e3982283cc0e146ada,
title = "Axillary radiotherapy instead of axillary dissection: A randomized trial",
abstract = "Background: Surgical dissection of the axilla is a standard part of the treatment of breast cancer but, by itself, does not improve prognosis; furthermore, most patients with small-sized breast cancer and a clinically uninvolved axilla never develop axillary metastases. We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT). Methods: From 1995 to 1998, 435 patients older than 45 years with breast cancer up to 1.2 cm were randomized, 214 to breast conservation without axillary treatment and 221 to breast conservation plus axillary RT. Results: After a follow-up of 28 to 68 months (median, 42 months), two women (1{\%}) in the no axillary treatment group and one (.5{\%}) in the axillary RT group developed axillary metastases. Rates of distant metastases and local treatment failure were also very low, and 5-year overall survival was 99{\%}. Conclusions: After a mean of 46 months of follow-up, our results indicate that axillary dissection can be safely avoided in patients with very small invasive carcinomas and a clinically negative axilla. Whether axillary RT should be added can be assessed only by longer follow-up.",
keywords = "Axillary radiotherapy, Breast cancer, Lymph nodes, Metastases, Randomized trial",
author = "Stefano Zurrida and Roberto Orecchia and Viviana Galimberti and Alberto Luini and Irene Giannetti and Bettina Ballardini and Andrea Amadori and Giulia Veronesi and Umberto Veronesi",
year = "2002",
doi = "10.1245/aso.2002.9.2.156",
language = "English",
volume = "9",
pages = "156--160",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - Axillary radiotherapy instead of axillary dissection

T2 - A randomized trial

AU - Zurrida, Stefano

AU - Orecchia, Roberto

AU - Galimberti, Viviana

AU - Luini, Alberto

AU - Giannetti, Irene

AU - Ballardini, Bettina

AU - Amadori, Andrea

AU - Veronesi, Giulia

AU - Veronesi, Umberto

PY - 2002

Y1 - 2002

N2 - Background: Surgical dissection of the axilla is a standard part of the treatment of breast cancer but, by itself, does not improve prognosis; furthermore, most patients with small-sized breast cancer and a clinically uninvolved axilla never develop axillary metastases. We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT). Methods: From 1995 to 1998, 435 patients older than 45 years with breast cancer up to 1.2 cm were randomized, 214 to breast conservation without axillary treatment and 221 to breast conservation plus axillary RT. Results: After a follow-up of 28 to 68 months (median, 42 months), two women (1%) in the no axillary treatment group and one (.5%) in the axillary RT group developed axillary metastases. Rates of distant metastases and local treatment failure were also very low, and 5-year overall survival was 99%. Conclusions: After a mean of 46 months of follow-up, our results indicate that axillary dissection can be safely avoided in patients with very small invasive carcinomas and a clinically negative axilla. Whether axillary RT should be added can be assessed only by longer follow-up.

AB - Background: Surgical dissection of the axilla is a standard part of the treatment of breast cancer but, by itself, does not improve prognosis; furthermore, most patients with small-sized breast cancer and a clinically uninvolved axilla never develop axillary metastases. We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT). Methods: From 1995 to 1998, 435 patients older than 45 years with breast cancer up to 1.2 cm were randomized, 214 to breast conservation without axillary treatment and 221 to breast conservation plus axillary RT. Results: After a follow-up of 28 to 68 months (median, 42 months), two women (1%) in the no axillary treatment group and one (.5%) in the axillary RT group developed axillary metastases. Rates of distant metastases and local treatment failure were also very low, and 5-year overall survival was 99%. Conclusions: After a mean of 46 months of follow-up, our results indicate that axillary dissection can be safely avoided in patients with very small invasive carcinomas and a clinically negative axilla. Whether axillary RT should be added can be assessed only by longer follow-up.

KW - Axillary radiotherapy

KW - Breast cancer

KW - Lymph nodes

KW - Metastases

KW - Randomized trial

UR - http://www.scopus.com/inward/record.url?scp=0036207216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036207216&partnerID=8YFLogxK

U2 - 10.1245/aso.2002.9.2.156

DO - 10.1245/aso.2002.9.2.156

M3 - Article

C2 - 11888872

AN - SCOPUS:0036207216

VL - 9

SP - 156

EP - 160

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 2

ER -